DYNHealthcareMid-Cap
Dyne Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Dyne Therapeutics, Inc. (DYN), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are DYN insiders buying or selling?
Dyne Therapeutics, Inc. insiders reported 15 open-market buys ($93.6M) and 184 sells ($344.9M) across 199 Form 4 filings — a net selling position of $251.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 8, 2026)
Total Form 4 filings
199
SEC EDGAR
Insider filers
20
Insider buys (15)
$93.6M
Insider sells (184)
$344.9M
Insider sentiment
Net sellingNet insider flow of $251.3M in net selling. 4 insider buys in the last 90 days.
Recent DYN insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Jason P Rhodes | Director | Sale | 777.5K | $22.97 | $17.9M |
| Jun 30, 2026 | Jason P Rhodes | Director | Sale | 504.7K | $21.23 | $10.7M |
| Jun 26, 2026 | Erick Lucera | Chief Financial Officer | Sale | 2.4K | $20.37 | $48.1K |
| Jun 26, 2026 | Jason P Rhodes | Director | Sale | 267.8K | $21.09 | $5.6M |
| Jun 24, 2026 | Dirk Kersten | Director | Sale | 264.0K | $20.70 | $5.5M |
| Jun 22, 2026 | Dirk Kersten | Director | Sale | 84.4K | $20.10 | $1.7M |
| Jun 17, 2026 | Douglas Kerr | Chief Medical Officer | Sale | 887 | $18.33 | $16.3K |
| Jun 17, 2026 | Johanna Friedl-Naderer | Chief Commercial Officer | Sale | 145 | $18.33 | $2.7K |
| Jun 17, 2026 | John Cox | CEO & President | Sale | 2.7K | $18.33 | $49.2K |
| Jun 9, 2026 | Brian S Posner | Director | Purchase | 2.0K | $16.94 | $33.9K |
| Jun 5, 2026 | Brian S Posner | Director | Purchase | 2.5K | $17.48 | $43.7K |
| May 28, 2026 | Brian S Posner | Director | Purchase | 2.0K | $18.21 | $36.4K |
| May 22, 2026 | Brian S Posner | Director | Purchase | 2.5K | $17.12 | $42.8K |
| May 14, 2026 | Johanna Friedl-Naderer | Chief Commercial Officer | Sale | 228 | $18.36 | $4.2K |
| May 14, 2026 | Douglas Kerr | Chief Medical Officer | Sale | 1.6K | $18.36 | $28.7K |
| May 14, 2026 | Erick Lucera | Chief Financial Officer | Sale | 1.4K | $18.36 | $26.6K |
| May 14, 2026 | John Cox | CEO & President | Sale | 3.3K | $18.36 | $60.8K |
| May 6, 2026 | Jason P Rhodes | Director | Sale | 106.7K | $18.14 | $1.9M |
| Apr 30, 2026 | Jason P Rhodes | Director | Sale | 227.3K | $18.38 | $4.2M |
| Apr 27, 2026 | Jason P Rhodes | Director | Sale | 384.5K | $18.47 | $7.1M |
| Apr 23, 2026 | Dirk Kersten | Director | Sale | 11.0K | $20.01 | $219.2K |
| Apr 22, 2026 | Jason P Rhodes | Director | Sale | 834.3K | $19.75 | $16.5M |
| Apr 21, 2026 | Dirk Kersten | Director | Sale | 337.2K | $20.21 | $6.8M |
| Apr 17, 2026 | Dirk Kersten | Director | Sale | 99.6K | $20.35 | $2.0M |
| Apr 3, 2026 | Erick Lucera | Chief Financial Officer | Sale | 5.7K | $18.64 | $106.8K |
Showing the 25 most recent of 199 Form 4 filings for Dyne Therapeutics, Inc..
Most active DYN insiders
- Dirk Kersten32 filings
- Richard William Scalzo26 filings
- Oxana Beskrovnaya22 filings
- Susanna Gatti High19 filings
- Jonathan Mcneill18 filings
Ask anything about DYN insider activity
Use Trabud's AI agent to query Dyne Therapeutics, Inc.'s Form 4 history in plain English — "Show me DYN CEO purchases this year" or compare it against any other ticker.
Open the AI agentDYN insider trading FAQ
Are Dyne Therapeutics, Inc. insiders buying or selling?
Across 199 SEC Form 4 filings, Dyne Therapeutics, Inc. (DYN) insiders reported 15 open-market purchases totaling $93.6M and 184 sales totaling $344.9M. That is a net selling position of $251.3M.
How many insiders trade DYN stock?
20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Dyne Therapeutics, Inc.. The most recent filing was accepted on Jul 8, 2026.
Where does Trabud get DYN insider trading data?
All DYN insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.